INSTITUTION'S PROFILE
University of Alabama-Birmingham, Birmingham, AL, USA.
Publications (1)
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Journal: The lancet. HIV
Publication date: 2023
Journal: The lancet. HIV
Publication Year: 2023